QQQE Direxion NASDAQ-100 Equal Weighted Index ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| INSM | 1.21% |
| ARM | 1.15% |
| MRVL | 1.14% |
| CSX | 1.09% |
| MELI | 1.07% |
| ALNY | 1.07% |
| ODFL | 1.07% |
| PDD | 1.07% |
| ORLY | 1.07% |
| FAST | 1.07% |
ETF Analysis
Fund Overview
Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE) currently reports 101 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is INSM (1.21%), ARM (1.15%), MRVL (1.14%), with INSM as the largest single weight at 1.21%. Together, the top three holdings account for 3.50%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.
Profitability & Capital Efficiency
From a capital efficiency perspective, ROIC is 21.45%, WACC is 9.90%, and the economic spread is 11.54%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 28.67% and ROA at 8.61%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
Valuation currently screens at trailing P/E of 24.64, forward P/E of 18.43, PEG of 1.90. Trailing and forward multiples are somewhat apart, indicating the market is pricing measured earnings growth without aggressive expansion assumptions. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. At 2.01, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.
Margins & Cash Generation
On the margin front: gross margin sits at 57.35%, operating margin at 19.78%, and free cash flow margin at 21.97%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.
Growth & Forward Outlook
The two main inputs to the near-term picture — TTM revenue growth of 18.19% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 33.8% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyAcross the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.